,0
zip,60064-6400
sector,Healthcare
fullTimeEmployees,50000
longBusinessSummary,"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal BehÃ§et's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."
city,North Chicago
phone,847 932 7900
state,IL
country,United States
companyOfficers,[]
website,https://www.abbvie.com
maxAge,1
address1,1 North Waukegan Road
industry,Drug Manufacturers—General
ebitdaMargins,0.49914002
profitMargins,0.20538001
grossMargins,0.69191
operatingCashflow,22776999936
revenueGrowth,0.074
operatingMargins,0.34750998
ebitda,28049999872
targetLowPrice,115
recommendationKey,buy
grossProfits,38883000000
freeCashflow,19250249728
targetMedianPrice,155
currentPrice,161.33
earningsGrowth,248.899
currentRatio,0.794
returnOnAssets,0.08217
numberOfAnalystOpinions,23
targetMeanPrice,152.79
debtToEquity,502.701
returnOnEquity,0.80952
targetHighPrice,172
totalCash,9829999616
totalDebt,77596999680
totalRevenue,56197001216
totalCashPerShare,5.558
financialCurrency,USD
revenuePerShare,31.75
quickRatio,0.563
recommendationMean,2.1
exchange,NYQ
shortName,AbbVie Inc.
longName,AbbVie Inc.
exchangeTimezoneName,America/New_York
exchangeTimezoneShortName,EDT
isEsgPopulated,False
gmtOffSetMilliseconds,-14400000
quoteType,EQUITY
symbol,ABBV
messageBoardId,finmb_141885706
market,us_market
annualHoldingsTurnover,
enterpriseToRevenue,6.284
beta3Year,
enterpriseToEbitda,12.59
52WeekChange,0.5115713
morningStarRiskRating,
forwardEps,12.22
revenueQuarterlyGrowth,
sharesOutstanding,1766279936
fundInceptionDate,
annualReportExpenseRatio,
totalAssets,
bookValue,8.713
sharesShort,14892047
sharesPercentSharesOut,0.0084
fundFamily,
lastFiscalYearEnd,1640908800
heldPercentInstitutions,0.69053
netIncomeToCommon,11468000256
trailingEps,6.45
lastDividendValue,1.41
SandP52WeekChange,0.14403355
priceToBook,18.51601
heldPercentInsiders,0.00116
nextFiscalYearEnd,1703980800
yield,
mostRecentQuarter,1640908800
shortRatio,1.89
sharesShortPreviousMonthDate,1644883200
floatShares,1763836693
beta,0.7687
enterpriseValue,353148043264
priceHint,2
threeYearAverageReturn,
lastSplitDate,
lastSplitFactor,
legalType,
lastDividendDate,1649894400
morningStarOverallRating,
earningsQuarterlyGrowth,111.333
priceToSalesTrailing12Months,5.0706253
dateShortInterest,1647302400
pegRatio,4.41
ytdReturn,
forwardPE,13.202127
lastCapGain,
shortPercentOfFloat,0.0084
sharesShortPriorMonth,15392390
impliedSharesOutstanding,0
category,
fiveYearAverageReturn,
previousClose,160.28
regularMarketOpen,160.55
twoHundredDayAverage,124.14225
trailingAnnualDividendYield,0.033129524
payoutRatio,0.8062
volume24Hr,
regularMarketDayHigh,161.98
navPrice,
averageDailyVolume10Day,6899990
regularMarketPreviousClose,160.28
fiftyDayAverage,145.379
trailingAnnualDividendRate,5.31
open,160.55
toCurrency,
averageVolume10days,6899990
expireDate,
algorithm,
dividendRate,5.64
exDividendDate,1649808000
circulatingSupply,
startDate,
regularMarketDayLow,160.26
currency,USD
trailingPE,25.012403
regularMarketVolume,5129839
lastMarket,
maxSupply,
openInterest,
marketCap,284953935872
volumeAllCurrencies,
strikePrice,
averageVolume,7708473
dayLow,160.26
ask,165
askSize,800
volume,5129839
fiftyTwoWeekHigh,161.98
fromCurrency,
fiveYearAvgDividendYield,4.28
fiftyTwoWeekLow,104.17
bid,161.05
tradeable,False
dividendYield,0.0352
bidSize,1200
dayHigh,161.98
regularMarketPrice,161.33
preMarketPrice,
logo_url,https://logo.clearbit.com/abbvie.com
